Journal Impact Factor Finder
The Journal Impact Factor Finder is designed for situations where you know the type of metric range you are looking for but do not yet have a specific journal in mind. Use the filters to narrow the directory by available JIF values, metric year, quartile or publisher.
How to use the finder
Start with one or two filters rather than making the search too narrow. For example, you might select a metric year and a JIF range, then review the results before applying a quartile or publisher filter. This makes it easier to see how many journals are available within the current dataset.
What the results mean
The Journal Impact Factor is a journal-level citation metric reported in Journal Citation Reports. A higher JIF does not automatically mean that a journal is the best choice for every manuscript. Citation patterns vary considerably between disciplines, so comparisons are most meaningful among journals working in similar subject areas.
Where available, the results may also show five-year JIF, Journal Citation Indicator, quartile and category rank. These additional measures can provide useful context, especially when two journals have similar JIF values.
Records with missing or placeholder JIF values are excluded from the finder. For any decision involving submission, assessment, promotion or institutional reporting, verify the current metric with the official source.
Filter the directory using available journal-level metrics. Filters use the values stored in this database.
19,758 matching journals
Sorted by JIF
| Journal | JIF | 5-Year JIF | JCI | Quartile | Rank | Year | Publisher |
|---|---|---|---|---|---|---|---|
| CA-A CANCER JOURNAL FOR CLINICIANS 0007-9235 | 232.400 | 353.000 | 112.160 | Q1 | 1/326 | 2025 | WILEY |
| NATURE REVIEWS MICROBIOLOGY 1740-1526 | 103.300 | 99.100 | 9.860 | Q1 | 1/163 | 2025 | NATURE PORTFOLIO |
| NATURE REVIEWS DRUG DISCOVERY 1474-1776 | 101.800 | 129.800 | 13.950 | Q1 | 1/352 | 2025 | NATURE PORTFOLIO |
| NATURE REVIEWS MOLECULAR CELL BIOLOGY 1471-0072 | 90.200 | 128.700 | 7.940 | Q1 | 1/204 | 2025 | NATURE PORTFOLIO |
| Kidney International Supplements 2157-1724 | 89.600 | 26.000 | 5.880 | Q1 | 1/133 | 2025 | ELSEVIER SCIENCE INC |
| LANCET 0140-6736 | 88.500 | 104.800 | 23.280 | Q1 | 1/332 | 2025 | ELSEVIER SCIENCE INC |
| Nature Reviews Materials 2058-8437 | 86.200 | 99.800 | 4.420 | Q1 | 1/460 | 2025 | NATURE PORTFOLIO |
| Nature Reviews Clinical Oncology 1759-4774 | 82.200 | 89.900 | 11.950 | Q1 | 2/326 | 2025 | NATURE PORTFOLIO |
| NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 | 78.500 | 84.900 | 23.300 | Q1 | 2/332 | 2025 | MASSACHUSETTS MEDICAL SOC |
| Nature Reviews Earth & Environment N/A | 71.500 | 73.700 | 5.960 | Q1 | 1/374 | 2025 | SPRINGERNATURE |
| NATURE REVIEWS CANCER 1474-175X | 66.800 | 81.000 | 9.040 | Q1 | 3/326 | 2025 | NATURE PORTFOLIO |
| World Psychiatry 1723-8617 | 65.800 | 60.000 | 12.180 | Q1 | 1/288 | 2025 | WILEY |
| ANNALS OF ONCOLOGY 0923-7534 | 65.400 | 46.800 | 8.380 | Q1 | 4/326 | 2025 | ELSEVIER |
| Living Reviews in Relativity 2367-3613 | 62.500 | 52.400 | 5.860 | Q1 | 31-Jan | 2025 | SPRINGER INT PUBL AG |
| NATURE REVIEWS IMMUNOLOGY 1474-1733 | 60.900 | 77.600 | 7.860 | Q1 | 1/183 | 2025 | NATURE PORTFOLIO |
| Nature Reviews Disease Primers 2056-676X | 60.600 | 104.800 | 21.180 | Q1 | 3/332 | 2025 | NATURE PORTFOLIO |
| MMWR Recommendations and Reports 1057-5987 | 60.100 | 50.000 | 10.910 | Q1 | 1/419 | 2025 | CENTERS DISEASE CONTROL & PREVENTION |
| Nature Energy 2058-7546 | 60.100 | 68.900 | 8.480 | Q1 | 2/460 | 2025 | NATURE PORTFOLIO |
| Nature Reviews Methods Primers N/A | 56.000 | 66.900 | 9.390 | Q1 | 1/135 | 2025 | SPRINGERNATURE |
| CHEMICAL REVIEWS 0009-2665 | 55.800 | 67.500 | 4.030 | Q1 | 1/239 | 2025 | AMER CHEMICAL SOC |
| JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 0098-7484 | 55.000 | 64.700 | 11.470 | Q1 | 4/332 | 2025 | AMER MEDICAL ASSOC |
| Signal Transduction and Targeted Therapy 2095-9907 | 52.700 | 52.200 | 5.040 | Q1 | 1/319 | 2025 | SPRINGERNATURE |
| NATURE REVIEWS GENETICS 1471-0056 | 52.000 | 57.100 | 6.660 | Q1 | 1/191 | 2025 | NATURE PORTFOLIO |
| Nature Reviews Chemistry N/A | 51.700 | 49.400 | 3.280 | Q1 | 2/239 | 2025 | NATURE PORTFOLIO |
| Nature Reviews Gastroenterology & Hepatology 1759-5045 | 51.000 | 72.400 | 8.100 | Q1 | 1/147 | 2025 | NATURE PORTFOLIO |
| NATURE MEDICINE 1078-8956 | 50.000 | 52.400 | 11.030 | Q1 | 1/195 | 2025 | NATURE PORTFOLIO |
| MMWR Surveillance Summaries 1545-8636 | 49.800 | 34.100 | 15.950 | Q1 | 2/419 | 2025 | CENTERS DISEASE CONTROL & PREVENTION |
| NATURE 0028-0836 | 48.500 | 55.000 | 11.120 | Q1 | 2/135 | 2025 | NATURE PORTFOLIO |
| IEEE Communications Surveys and Tutorials N/A | 46.700 | 42.800 | 10.200 | Q1 | 1/258 | 2025 | IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC |
| SCIENCE 0036-8075 | 45.800 | 49.700 | 8.980 | Q1 | 3/135 | 2025 | AMER ASSOC ADVANCEMENT SCIENCE |
| LANCET NEUROLOGY 1474-4422 | 45.500 | 56.200 | 12.190 | Q1 | 1/285 | 2025 | ELSEVIER SCIENCE INC |
| REVIEWS OF MODERN PHYSICS 0034-6861 | 44.800 | 56.300 | 4.080 | Q1 | 1/114 | 2025 | AMER PHYSICAL SOC |
| Nature Catalysis 2520-1158 | 44.600 | 47.400 | 5.630 | Q1 | 1/185 | 2025 | NATURE PORTFOLIO |
| CANCER CELL 1535-6108 | 44.500 | 47.200 | 8.110 | Q1 | 5/326 | 2025 | CELL PRESS |
| Nature Reviews Cardiology 1759-5002 | 44.200 | 52.900 | 8.320 | Q1 | 1/230 | 2025 | NATURE PORTFOLIO |
| BMJ-British Medical Journal 0959-535X | 42.700 | 76.100 | 9.960 | Q1 | 5/332 | 2025 | BMJ PUBLISHING GROUP |
| CELL 0092-8674 | 42.500 | 48.900 | 7.990 | Q1 | 3/319 | 2025 | CELL PRESS |
| JOURNAL OF CLINICAL ONCOLOGY 0732-183X | 41.900 | 37.700 | 6.680 | Q1 | 6/326 | 2025 | LIPPINCOTT WILLIAMS & WILKINS |
| Lancet Diabetes & Endocrinology 2213-8587 | 41.800 | 41.700 | 8.500 | Q1 | 1/191 | 2025 | ELSEVIER SCIENCE INC |
| NATURE BIOTECHNOLOGY 1087-0156 | 41.700 | 59.500 | 8.570 | Q1 | 2/177 | 2025 | NATURE PORTFOLIO |
| Nature Electronics 2520-1131 | 40.900 | 42.000 | 5.800 | Q1 | 1/366 | 2025 | NATURE PORTFOLIO |
| Journal of Hematology & Oncology N/A | 40.400 | 34.400 | 5.040 | Q1 | Jan-98 | 2025 | BMC |
| Nature Reviews Endocrinology 1759-5029 | 40.000 | 47.000 | 4.950 | Q1 | 2/191 | 2025 | NATURE PORTFOLIO |
| PROGRESS IN MATERIALS SCIENCE 0079-6425 | 40.000 | 44.800 | 2.420 | Q1 | 3/460 | 2025 | PERGAMON-ELSEVIER SCIENCE LTD |
| Nature Reviews Nephrology 1759-5061 | 39.800 | 44.500 | 7.360 | Q1 | 2/133 | 2025 | NATURE PORTFOLIO |
| Nature Reviews Physics N/A | 39.500 | 53.200 | 3.030 | Q1 | 1/187 | 2025 | NATURE PORTFOLIO |
| CHEMICAL SOCIETY REVIEWS 0306-0012 | 39.000 | 50.100 | 2.950 | Q1 | 3/239 | 2025 | ROYAL SOC CHEMISTRY |
| CIRCULATION 0009-7322 | 38.600 | 35.900 | 9.010 | Q1 | Jan-98 | 2025 | LIPPINCOTT WILLIAMS & WILKINS |
| Lancet Gastroenterology & Hepatology N/A | 38.600 | 34.000 | 6.900 | Q1 | 2/147 | 2025 | ELSEVIER INC |
| NATURE MATERIALS 1476-1122 | 38.500 | 46.800 | 5.990 | Q1 | Jan-79 | 2025 | NATURE PORTFOLIO |